You are on Trendlyne United States. Click here to go to India website or make United States as your default

Baxter International Inc. XNYS: BAX

Baxter International Inc. Live Share Price Today, Share Analysis and Chart

34.23 0.48 (1.42%)

3.3M XNYS Volume

XNYS 31 Mar, 2025 4:00 PM (EDT)

Baxter International Inc. Key Metrics

Select
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
22.2 / 100
Expensive Valuation
27.5 / 100
Technically Neutral
46.3 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

Baxter International Inc. Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '2610k12.5k15k17.5kActual RevenueAvg. Estimate
Hit

Baxter International Inc.'s Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
-1.3
Avg. Estimate
1.2
Low Estimate
0.7
High Estimate
1.5
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 190.6% in FY25

Consensus Recommendation

18 ANALYST Recommendations
HOLD

Created with Highcharts 7.2.21Strong Sell11Hold3Buy3Strong Buy

The consensus recommendation from 18 analysts for Baxter International Inc. is HOLD

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Baxter International Inc. Stock Analysis

Baxter International Inc. stock analysis with key metrics, changes, and trends.

Baxter International Inc. MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$10,636 M2.66%positive

Annual Revenue rose 2.66%, in the last year to $10,636 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit$649 M124.44%negative

Annual Net Profit fell 124.44% in the last year to $649 M. Its sector's average net profit growth for the last fiscal year was 4.62%.

Price to Earning Ratio-27.05-negative

Price to Earning Ratio is -27.05, which is negative.

Stock Price$34.23-19.91%negative

Stock Price fell 19.91% and underperformed its sector by 25.42% in the past year.

Quarterly Revenue$2,753 M0.99%positive

Quarterly Revenue rose 0.99% YoY to $2,753 M. Its sector's average revenue growth YoY for the quarter was 8.49%.

Quarterly Net profit$512 M308.98%negative

Quarterly Net profit fell 308.98% YoY to $512 M. Its sector's average net profit growth YoY for the quarter was 28.14%.

Debt to Equity Ratio1.93-negative

Debt to Equity Ratio of 1.93 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE)-8.45 %-8.45%negative

Return on Equity(ROE) for the last financial year was -8.45%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding79.47 %0.41%positive

Mutual Fund Holding increased by 0.41% in the last quarter to 79.47.

Promoter Share Holding0.21 %-0.01%negative

Promoter Share Holding decreased by 0.01% in the most recent quarter to 0.21%.

Interest Coverage Ratio0.29-negative

Interest Coverage Ratio is 0.29, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding95.14 %0%neutral

Institutional Holding remained the same in the last quarter at 95.14%.

VIEW LESS


Loading data..

Baxter International Inc. - Company Profile

What does Baxter International Inc. do?

Baxter International Inc offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Baxter International Inc. Management structure

All Gross Remunerations are in USD
Mr. Joel T. Grade
Executive Vice President and Chief Financial Officer
-
2025
Gross Remuneration
Year
Mr. Jose E. Almeida
Chairman of the Board, Chief Executive Officer and President
-
2025
Gross Remuneration
Year
Mr. D. Brent Shafer
Interim Chief Executive Officer and Chairman of the Board
-
2025
Gross Remuneration
Year
Mr. Christopher A. Toth
Executive Vice President and Group President, Kidney Care
-
2025
Gross Remuneration
Year
Ms. Heather L. Knight
Executive Vice President, Chief Operating Officer and Interim Group President, Medical Products and Therapies
-
2025
Gross Remuneration
Year
Ms. Anita A. Zielinski
Senior Vice President, Chief Accounting Officer and Controller
-
2025
Gross Remuneration
Year

Baxter International Inc. Board of directors

All Gross Remunerations are in USD
Mr. Jose E. Almeida
Chairman of the Board, Chief Executive Officer and
-
2025
Gross Remuneration
Year
Mr. D. Brent Shafer
Interim Chief Executive Officer and Chairman of th
-
2025
Gross Remuneration
Year

Baxter International Inc. FAQ

How is Baxter International Inc. today?
Baxter International Inc. today is trading in the green, and is up by 1.42% at 34.23.
Baxter International Inc. is currently trading up 1.42% on an intraday basis. In the past week the stock rose 3.13%. stock has been up 19.56% in the past quarter and fell -19.91% in the past year. You can view this in the overview section.